Last reviewed · How we verify

NCT02526576: SVF

A Phase II Double-blind, Randomized, Study to Assess the Efficacy of Facial Fat Grafts Supplemented With Autologous, Adipose Derived Stromal Vascular Fraction (SVF)

Completed Phase 2 Last updated 25 February 2019
What this trial tests

Phase 2 trial testing Stromal Vasular Fraction in Facial Atrophy in 34 participants. Completed in 1 July 2017.

Timeline
1 August 2015
Primary endpoint
1 July 2017
1 July 2017

Quick facts

Lead sponsorAntria
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment34
Start date1 August 2015
Primary completion1 July 2017
Estimated completion1 July 2017
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Antria — full company profile →

Who can join

Adults 18 to 70, any sex, with Facial Atrophy. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

This phase two, randomized, double-blind study is designed to demonstrate the enhanced efficacy of SVF-enriched autologous facial fat grafts, in relation to standard, non-SVF enriched, facial fat grafts by evaluating volumetric retention and contour of the engrafted region over the course of one year.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Mesenchymal Stem Cells from Adipose Tissue in Clinical Applications for Dermatological Indications and Skin Aging.
    Gaur M, Dobke M, Lunyak VV. · · 2017 · cited 105× · PMID 28117680 · DOI 10.3390/ijms18010208
  2. Concise Review: Fat and Furious: Harnessing the Full Potential of Adipose-Derived Stromal Vascular Fraction.
    Dykstra JA, Facile T, Patrick RJ, Francis KR, et al · · 2017 · cited 77× · PMID 28186685 · DOI 10.1002/sctm.16-0337
  3. The use of stem cells in aesthetic dermatology and plastic surgery procedures. A compact review of experimental and clinical applications.
    Nowacki M, Kloskowski T, Pietkun K, Zegarski M, et al · · 2017 · cited 7× · PMID 29422816 · DOI 10.5114/ada.2017.72456

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02526576.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing